180 related articles for article (PubMed ID: 1934534)
1. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.
Buchanan CR; Maheshwari HG; Norman MR; Morrell DJ; Preece MA
Clin Endocrinol (Oxf); 1991 Aug; 35(2):179-85. PubMed ID: 1934534
[TBL] [Abstract][Full Text] [Related]
2. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.
Laron Z; Klinger B; Erster B; Silbergeld A
Acta Endocrinol (Copenh); 1989 Oct; 121(4):603-8. PubMed ID: 2800930
[TBL] [Abstract][Full Text] [Related]
3. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.
Baumann G; Shaw MA; Winter RJ
J Clin Endocrinol Metab; 1987 Oct; 65(4):814-6. PubMed ID: 3654924
[TBL] [Abstract][Full Text] [Related]
4. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).
Daughaday WH; Trivedi B
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4636-40. PubMed ID: 3474620
[TBL] [Abstract][Full Text] [Related]
5. [A case of dwarfism with severely reduced activity of growth hormone-binding protein].
Igarashi N; Sato T
Nihon Naibunpi Gakkai Zasshi; 1991 Oct; 67(10):1219-29. PubMed ID: 1752341
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive growth hormone receptor/binding protein is present on fibroblasts and in serum of Laron-type dwarfs.
Oakes SR; Haynes KM; Batch J; Ennis G; Waters MJ; Daughaday W; Herington AC; Werther GA
Mol Cell Endocrinol; 1994 Feb; 99(1):125-32. PubMed ID: 8187955
[TBL] [Abstract][Full Text] [Related]
7. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
8. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
Laron Z; Klinger B; Blum WF; Silbergeld A; Ranke MB
Clin Endocrinol (Oxf); 1992 Mar; 36(3):301-4. PubMed ID: 1373347
[TBL] [Abstract][Full Text] [Related]
9. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
[TBL] [Abstract][Full Text] [Related]
10. Laron dwarfism and mutations of the growth hormone-receptor gene.
Amselem S; Duquesnoy P; Attree O; Novelli G; Bousnina S; Postel-Vinay MC; Goossens M
N Engl J Med; 1989 Oct; 321(15):989-95. PubMed ID: 2779634
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
Laron Z; Klinger B; Jensen LT; Erster B
Clin Endocrinol (Oxf); 1991 Aug; 35(2):145-50. PubMed ID: 1934530
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
Klinger B; Jensen LT; Silbergeld A; Laron Z
Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity.
Kanety H; Karasik A; Klinger B; Silbergeld A; Laron Z
Acta Endocrinol (Copenh); 1993 Feb; 128(2):144-9. PubMed ID: 7680834
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone induces insulin resistance in Laron dwarf cells via lactogenic receptors.
Geffner ME; Bersch N; Golde DW
J Clin Endocrinol Metab; 1993 Apr; 76(4):1039-47. PubMed ID: 8473379
[TBL] [Abstract][Full Text] [Related]
16. Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism.
Edery M; Rozakis-Adcock M; Goujon L; Finidori J; Lévi-Meyrueis C; Paly J; Djiane J; Postel-Vinay MC; Kelly PA
J Clin Invest; 1993 Mar; 91(3):838-44. PubMed ID: 8450064
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor type-1 receptor down-regulation associated with dwarfism in Holstein calves.
Blum JW; Elsasser TH; Greger DL; Wittenberg S; de Vries F; Distl O
Domest Anim Endocrinol; 2007 Oct; 33(3):245-68. PubMed ID: 16829014
[TBL] [Abstract][Full Text] [Related]
18. Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome.
Duquesnoy P; Sobrier ML; Amselem S; Goossens M
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10272-6. PubMed ID: 1719554
[TBL] [Abstract][Full Text] [Related]
19. Laron syndrome due to a post-receptor defect: response to IGF-I treatment.
Laron Z; Klinger B; Eshet R; Kaneti H; Karasik A; Silbergeld A
Isr J Med Sci; 1993 Dec; 29(12):757-63. PubMed ID: 8300382
[TBL] [Abstract][Full Text] [Related]
20. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
